Name: Caribou Biosciences, Inc. (CRBU) Balance Sheet
Creator: FinSpry

Caribou Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Caribou Biosciences, Inc. (CRBU) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	16.29	328.83	58.34	240.42	15.95
Short-Term Investments	193.24	277.67	189.33	135.41	0.00
Cash & Short-Term Investments	209.54	328.83	247.66	375.83	15.95
Accounts Receivable	0.27	3.86	0.20	1.15	5.16
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.78	4.09	1.12	0.67	1.82
Total Current Assets	219.38	338.84	260.25	391.19	24.31
Non-Current Assets
Property, Plant & Equipment (Net)	39.29	40.45	34.91	4.89	3.50
Long-Term Investments	49.13	51.33	77.07	45.30	7.63
Other Non-Current Assets	5.52	1.59	1.54	0.98	0.61
Total Non-Current Assets	93.94	93.37	113.52	51.16	0.00
Total Assets	313.31	432.21	373.77	442.36	36.05
Current Liabilities
Accounts Payable	2.48	24.26	1.15	3.99	2.60
Short-Term Debt	1.43	0.00	0.00	0.00	0.65
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	0.65
Accrued Liabilities	13.40	10.51	8.96	8.12	8.15
Deferred Revenue	3.13	2.85	9.94	8.70	0.16
Other Current Liabilities	1.66	2.94	1.37	0.79	0.82
Total Current Liabilities	30.65	28.30	28.13	25.83	12.39
Non-Current Liabilities
Long-Term Debt	25.06	25.91	26.78	0.00	0.92
Deferred Tax Liabilities	0.55	0.56	0.38	0.48	0.16
Other Non-Current Liabilities	0.79	8.95	1.65	4.10	3.66
Total Non-Current Liabilities	29.71	32.57	44.77	28.70	0.00
Total Liabilities	60.36	63.81	72.89	54.53	18.16
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-448.39	-299.26	-197.22	-97.79	-30.87
Accumulated Other Comprehensive Income	0.26	0.03	-1.52	-0.14	0.00
Additional Paid-in Capital	701.08	667.65	499.60	485.75	0.00
Shares Outstanding	92.38	88.45	61.03	60.26	0.00
Total Stockholders' Equity	252.95	368.40	300.87	387.83	17.89
Total Liabilities & Equity	313.31	432.21	373.77	442.36	0.00